Marc G. Caron

Duke University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

175h-index99.2kcitations810works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(517), Neurotransmitter Receptor Influence on Behavior(207), Neuroscience and Neuropharmacology Research(189), Neuropeptides and Animal Physiology(182), Pharmacological Effects and Assays(72)

Publications809 total

Dopamine receptors in GtoPdb v.2025.3
IUPHAR/BPS Guide to Pharmacology CITE·2025Open Access
Arrestin-biased allosteric modulator of neurotensin receptor 1 alleviates acute and chronic pain
Cell·2025· 17 cited
Combination of Haloperidol With UNC9994, β-arrestin-Biased Analog of Aripiprazole, Ameliorates Schizophrenia-Related Phenotypes Induced by NMDAR Deficit in Mice
The International Journal of Neuropsychopharmacology·2024· 1 citedOpen Access
hCALCRL mutation causes autosomal recessive nonimmune hydrops fetalis with lymphatic dysplasia
UNC Libraries·2024· 2 citedOpen Access
Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator
Carolina Digital Repository (University of North Carolina at Chapel Hill)·2024Open Access
Combination of Haloperidol with UNC9994, β-arrestin-biased analog of Aripiprazole, ameliorates schizophrenia-related phenotypes induced by NMDAR deficit in mice
2024· 1 citedOpen Access
Dopamine-Depleted Dopamine Transporter Knockout (DDD) Mice: Dyskinesia with L-DOPA and Dopamine D1 Agonists
Biomolecules·2023· 1 citedOpen Access
Dopamine receptors in GtoPdb v.2023.1
IUPHAR/BPS Guide to Pharmacology CITE·2023· 3 citedOpen Access
Neurotensin receptor 1-biased ligand attenuates neurotensin-mediated excitation of ventral tegmental area dopamine neurons and dopamine release in the nucleus accumbens
Neuropharmacology·2023· 8 citedOpen Access
Movie 3 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
Supplementary Figure 5 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
Supplementary Figure 1 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
Data from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
Supplementary Figure 7 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
Supplementary Figure 3 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
Movie 5 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
Movie 3 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
Supplementary Figure 3 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
Supplementary Figure 6 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
Supplementary Figure 4 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
2023Open Access
page 1 of 41Next →

Frequent Co-authors

Robert J. Lefkowitz(24), Raul R. Gainetdinov(17), Stephen S. G. Ferguson(6), Brian K. Kobilka(6), Larry S. Barak(6), Sara R. Jones(6), Jean‐Martin Beaulieu(5), Tatyana D. Sotnikova(5), Mohamed Jaber(4), Jeffrey Benovic(4), Laura Bohn(4), Stéphane A. Laporte(4), Bruno Giros(4), Fang‐Tsyr Lin(3), Henrik Dohlman(3), Thomas Frielle(3), Robert H. Oakley(3), Jason A. Holt(3), Tong Sun Kobilka(3), Uta Francke(3)